CoReCCT

  • Research type

    Research Study

  • Full title

    Confederation of Respiratory Critical Care Trials

  • IRAS ID

    335630

  • Contact name

    Danny McAuley

  • Contact email

    d.f.mcauley@qub.ac.uk

  • Sponsor organisation

    University of Warwick

  • ISRCTN Number

    ISRCTN63784375

  • Duration of Study in the UK

    4 years, 11 months, 30 days

  • Research summary

    CoReCCT (the Confederation of Respiratory Critical Care Trials) has been established as a novel concept to group a range of respiratory critical care trials, with an overarching aim to streamline trial delivery across areas such as governance, contracting, and data collection. The overriding objective is to improve deliverability by minimising burden on participating sites and participants.

    The primary aim of the clinical trials (domains) within CoReCCT is to test the clinical and cost effectiveness of four interventional strategies on the patient outcomes in hospitalised adults with moderate to severe acute respiratory failure that may require tracheal intubation and mechanical ventilation support.

    The interventional strategies are presented as a series of clinical trials (domains), which occur both sequentially and concurrently along the clinical care pathway of a patient with moderate to severe acute respiratory failure. These domains include the Awake Prone Study (pre-intubation), PROTECT Airways trial (intubation), RELEASE trial and NAVA trial (both post-intubation).

  • REC name

    Wales REC 2

  • REC reference

    24/WA/0128

  • Date of REC Opinion

    9 Jul 2024

  • REC opinion

    Further Information Favourable Opinion